Frances Stocks AllenAssociate at Latham & Watkins LLP, UK
Frances Stocks Allen advises leading life sciences companies and industry investors on a range of technology-based commercial matters, including complex licenses, collaborations, acquisitions, and divestments.
Ms. Stocks Allen provides sophisticated commercial, transactional, and regulatory advice to multinational, European, and US-based companies and investors in the biotech, pharmaceutical, and medical devices sectors. Her work includes licensing and other complex commercial and intellectual property arrangements. She brings particular experience in relation to UK and EU regulations and data privacy, including the General Data Protection Regulation (GDPR).
Ms. Stocks Allen helps clients anticipate and navigate legal challenges by drawing on her secondment experience, including in-house at Allergan and at the firm’s Silicon Valley office. She provides pragmatic, commercially driven, and digestible advice to help clients achieve their business objectives and strategic goals.
Ms. Stocks Allen frequently writes on topics related to legal issues in the life sciences sector, including for industry publications such as Law360 and Privacy Laws & Business.
Ms. Stocks Allen is a member of the firm’s Mentoring Committee, and previously served as a global leader of the Women’s Leadership Group.
Ms. Stocks Allen was identified as a Legal 500 Rising Star 2020 in Life Sciences and Healthcare: "Frances Stocks Allen stands out as a rising star. She is highly knowledgeable and always available, with a pragmatic approach, good business acumen and short response times." She was also part of a team of Latham lawyers who received TrustLaw’s Lawyer of the Year Award — an honor that recognizes outstanding pro bono service.